These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37052748)
1. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group. Yamashita S; Takeshima H; Hata N; Uchida H; Shinojima N; Yokogami K; Nakano Y; Sakata K; Fudaba H; Enomoto T; Nakahara Y; Ujifuku K; Sugawara K; Iwaki T; Sangatsuda Y; Yoshimoto K; Hanaya R; Mukasa A; Suzuki K; Yamamoto J; Negoto T; Nakamura H; Momii Y; Fujiki M; Abe H; Masuoka J; Abe T; Matsuo T; Ishiuchi S; J Neurooncol; 2023 Apr; 162(2):425-433. PubMed ID: 37052748 [TBL] [Abstract][Full Text] [Related]
2. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade. Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation. Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072 [TBL] [Abstract][Full Text] [Related]
4. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397 [TBL] [Abstract][Full Text] [Related]
5. A Pineal Parenchymal Tumor of Intermediate Differentiation in an Octogenarian Contains a Rare Jones VM; Kanter JH; Russo GA; Simmons NE; Tafe LJ; Zanazzi GJ Int J Surg Pathol; 2024 Aug; 32(5):962-969. PubMed ID: 37855103 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588 [TBL] [Abstract][Full Text] [Related]
7. Clinical Features of Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Single-Institution Series. Kunigelis KE; Kleinschmidt-DeMasters BK; Youssef AS; Lillehei KO; Ormond DR World Neurosurg; 2021 Nov; 155():e229-e235. PubMed ID: 34418607 [TBL] [Abstract][Full Text] [Related]
8. Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades. Takase H; Tanoshima R; Singla N; Nakamura Y; Yamamoto T Neurosurg Rev; 2022 Apr; 45(2):1135-1155. PubMed ID: 34668090 [TBL] [Abstract][Full Text] [Related]
9. Spinal Dissemination of Pineal Parenchymal Tumors of Intermediate Differentiation Over 10 Years After Initial Treatment: A Case Report. Miyazaki A; Makino K; Shinojima N; Yamashita S; Mikami Y; Mukasa A Cureus; 2024 Mar; 16(3):e57147. PubMed ID: 38681294 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis. Webb M; Johnson DR; Mahajan A; Brown P; Neth B; Kizilbash SH; Sener U J Neurooncol; 2022 Nov; 160(2):527-534. PubMed ID: 36301435 [TBL] [Abstract][Full Text] [Related]
11. Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors. Uchida E; Sasaki A; Shirahata M; Suzuki T; Adachi JI; Mishima K; Yasuda M; Fujimaki T; Ichimura K; Nishikawa R Brain Tumor Pathol; 2022 Jul; 39(3):130-138. PubMed ID: 35000018 [TBL] [Abstract][Full Text] [Related]
12. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis. Mallick S; Benson R; Rath GK Radiother Oncol; 2016 Nov; 121(2):204-208. PubMed ID: 27865543 [TBL] [Abstract][Full Text] [Related]
13. Malignant Pineal Parenchymal Tumors in Adults: A National Cancer Database Analysis. Chalif EJ; Murray RD; Mozaffari K; Chillakuru YR; Shim T; Monfared A; Sherman JH Neurosurgery; 2022 Jun; 90(6):807-815. PubMed ID: 35311743 [TBL] [Abstract][Full Text] [Related]
14. Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) and Papillary Tumor of Pineal Region (PTPR): A Review. Sadashiva N; Deora H; Arumalla K; Rao S; Saini J; Shukla D; Santosh V Neurol India; 2021; 69(5):1153-1164. PubMed ID: 34747779 [TBL] [Abstract][Full Text] [Related]
15. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Lee JC; Mazor T; Lao R; Wan E; Diallo AB; Hill NS; Thangaraj N; Wendelsdorf K; Samuel D; Kline CN; Banerjee A; Auguste K; Raffel C; Gupta N; Berger M; Raleigh DR; Shai A; Phillips JJ; Bollen AW; Tihan T; Perry A; Costello J; Solomon DA Acta Neuropathol; 2019 May; 137(5):851-854. PubMed ID: 30877433 [No Abstract] [Full Text] [Related]
16. Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation. Kang YJ; Bi WL; Dubuc AM; Martineau L; Ligon AH; Berkowitz AL; Aizer AA; Lee EQ; Ligon KL; Ramkissoon SH; Dunn IF World Neurosurg; 2016 Jan; 85():96-105. PubMed ID: 26226092 [TBL] [Abstract][Full Text] [Related]